Abstract
Fifty-year-old women (n=519) attending a health examination were divided by their ovarian hormone status into four groups: premenopausal, perimenopausal, postmenopausal without ovarian hormone replacement therapy (HRT), and postmenopausal with HRT. Information on lifestyle factors was obtained with interviews and questionnaires. Bone mineral density at the calcaneus was assessed with single-photon absorptiometry, and several serum and urine markers of bone metabolism were measured. Postmenopausal women without HRT had significantly higher levels of fasting serum alkaline phosphatase, osteocalcin, total and ionized calcium, phosphate, and fasting urinary hydroxyproline than those in the three other study groups. No difference was found in bone mineral density between the premenopausal and postmenopausal groups. Postmenopausal women without HRT showed a marked correlation between serum osteocalcin and urine hydroxyproline. Both markers showed significant correlations with serum calcium, phosphate, and alkaline phosphatase. Multivariate analyses showed a statistically significant association of ovarian hormone status and body mass index with most measured markers of bone metabolism. The association between alcohol consumption and serum osteocalcin was highly significant. Cigarette smoking was associated with levels of serum alkaline phosphatase and total and ionized calcium. A weak association was found between coffee drinking and serum alkaline phosphatase.
Similar content being viewed by others
References
Fehily AM, Coles RJ, Evans WD, Elwood PC (1992) Factors affecting bone density in young adults. Am J Clin Nutr 56:579–586
Hansen MA, Hassager C, Jensen SB, Christiansen C (1992) Is heritability a risk factor for postmenopausal osteoporosis? J Bone Miner Res 7:1037–1043
Aloia JF, Cohn SH, Vaswani A, Yeh JK, Yuen K, Ellis K (1985) Risk factors for postmenopausal osteoporosis. Am J Med 78: 95–100
Stevenson JC, Lees B, Devenport M, Cust MP, Ganger KF (1989) Determinants of bone density in normal women: risk factors for future osteoporosis? Br Med J 298:924–928
Smith EL, Gilligan C (1991) Physical activity effects on bone metabolism. Calcif Tissue Int 49:S50-S54
Rickers H, Deding AA, Christiansen C, Rodbro P (1984) Mineral loss in cortical and trabecular bone during high-dose prednisone treatment. Calcif Tissue Int 36:269–273
Nordin BEC, Need AGA, Chatterton BE (1990) The relative contributions of age and years after menopause to postmenopausal bone loss. J Endocrinol 70:83–88
Gallagher JC, Kable WT, Goldgar D (1991) Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen. Am J Med 90:171–178
Leino A, Impivaara O, Järvisalo J, Helenius H (1991) Factors related to risk of osteoporosis in 50-year-old women. Calcif Tissue Int 49:S76-S77
Knuts L-R, Rastas M, Haapala P, Seppänen R, Karvetti R-L, Aro A (1987) Nutrica—a computer program for calculation of food and nutrient intake (abstract) In: The 3rd meeting of Eurofoods, Warsaw, May 16, pp 24–27
Travis JC (1980) The conadotropins in “clinical radioimmunoassay state-of-the rat.” Radioassay-Ligand Assay Publishers, Anaheim, pp 73–76
Mertens R, Liedtke RJ, Batjer JD (1983) Evaluation of a radio-immunoassay for estradiol in unextracted serum. Clin Chem 29:1961–1963
The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology (1974) Recommended methods for the determination of four enzymes in blood. Scand J Clin Lab Invest 33:291–306
Price PA, Parthemore JG, Deftos LJ (1980) New biochemical marker for bone metabolism: measurement by radioimmunoassay of bone Gla-protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 66:878–883
Cali JP, Bowers GN, Young DS (1973) A referee method for the determination of total calcium in serum. Clin Chem 19:1208–1213
Fogh-Andersen O, Christiansen TF, Komarny L, Siggaard-Andersen O (1978) Measurements of free calcium ion in capillary blood and serum. Clin Chem 24:1545–1552
Reed P, Holbrook IB, McMurray JR, Gardner MLG (1988) Hydroxyproline measurement in urine: a simple optimized method using HPLC. Ann Clin Biochem 25:169S-170S
Degenaar CP (1983) The use of albumin in the direct phosphate determination. Clin Chim Acta 131:155–161
Cameron JR, Sorenson J (1963) Measurement of bone mineral in vivo: an improved method. Science 142:230–232
Rajala T (1991) Nutritional status of the elderly living in south-western Finland. Relationship between nutritional status, health status and functional capacity of the elderly living at home or in old people's homes. Publications of the Social Insurance Institution, Finland, ML:106, Turku (in Finnish with English summary)
SAS Users Guide: Statistics. Version 6. Cary, NC: SAS Institute, 1990
Topo P, Klaukka T, Hemminki E, Uutela A (1991) Use of hormone replacement therapy in 1976–89 by 45–64-year-old Finnish women. J Epid Comm Health 45:277–280
Hui SL, Slemeda CW, Johnston C, Appledorn CR (1987) Effects of age and menopause on vertebral bone density Bone Miner 2:141–146
Nordin BEC Polley KJ, Need AG, Morris HA, Horowitz H (1988) Calcium and osteoporosis. Ann Chirurg Gynaecol 77: 212–218
Stepan JJ, Posphical J, Presl J, Pacovsky V (1987) Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women. Bone 8:279–284
Delmas PD (1991) Biochemical markers of bone turnover: methodology and clinical use in osteoporosis. Am J Med 91:59S-63S
Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, Meuier PJ (1984) Serum bone gla protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1: 1091–1093
Johansen JS, Riis BJ, Delmas PD, Christiansen C (1988) Plasma BGP: an indicator of spontaneous bone loss and the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 18:191–195
Slemeda C, Hui SL, Longcope C, Johnston CC (1987) Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest 80:1261–1269
Jensen FG (1986) Osteoporosis of slender smoker revisited by epidemiologic approach. Eur J Clin Invest 16:239–242
Hansen MA, Overgaard, Riis BJ, Christiansen C (1991) Potential risk factors for development of postmenopausal osteoporosis—examined over a 12-year period. Osteoporosis Int 1:95–102
Diamond T, Stiel D, Lunzer M, Wilkinson M, Posen S (1989) Ethanol reduces bone formation and may cause osteoporosis. Am J Med 86:282–288
Bell NH, Turner RT, Greene VS (1987) Demonstration that ethanol inhibits bone matrix synthesis and mineralization in the rat. In: Cohn DV, Martin TJ, Meunier PT (eds) Calcium regulation and bone metabolism. Excerpta Medica, Amsterdam, p 636
Peng TC, Garner SC, Frye GD, Crenshaw MA (1982) Evidence of a toxic effect of ethanol on bone of rats. Alcohol Clin Exp Res 6:96–99
Horowitz M, Need AG, Philcox J, Nordin C (1984) Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women. Am J Clin Nutr 39:857–859
Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ (1993) Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 18:460–464
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leino, A., Järvisalo, J., Impivaara, O. et al. Ovarian hormone status, life-style factors, and markers of bone metabolism in women aged 50 years. Calcif Tissue Int 54, 262–267 (1994). https://doi.org/10.1007/BF00295948
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00295948